FDA Inspection
Cleveland ClinicCleveland Clinic – FDA Inspection, Apr 3, 2013
Record Details
This FDA Inspection record concerns Cleveland Clinic, with an inspection on April 3, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Cleveland Clinic
- Inspection Date
- April 3, 2013
- Product Type
- Biologics
View Company Profile
ID · ed1de785-5cf0-4517-ad98-af51fd2b1f12
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 824259
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cleveland Clinic
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 26, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 28, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 18, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 23, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 15, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Cleveland Clinic
- FDA Inspection 1262721 - 2025-02-26
- FDA Inspection 1253266 - 2024-10-28
- FDA Inspection 1177574 - 2022-07-18
- FDA Inspection 915235 - 2015-02-23
- FDA Inspection 796169 - 2012-08-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.